Related references
Note: Only part of the references are listed.Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates
B. Radesic et al.
HUMAN REPRODUCTION (2011)
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
P. Humaidan et al.
HUMAN REPRODUCTION UPDATE (2011)
1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study
Peter Humaidan et al.
FERTILITY AND STERILITY (2010)
Ovarian Hyperstimulation Syndrome Prevention Strategies: Reducing the Human Chorionic Gonadotropin Trigger Dose
Sonya Kashyap et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study
P. Humaidan
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome
Sergio Reis Soares et al.
HUMAN REPRODUCTION UPDATE (2008)
Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles
Geeta Nargund et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2007)
Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study
P. Humaidan et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome
S Kol
FERTILITY AND STERILITY (2004)
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization
BC Fauser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)